Dali Pharmaceuticalco.,Ltd (603963.SS)

CNY 2.96

(-3.27%)

Total Debt Summary of Dali Pharmaceuticalco.,Ltd

  • Dali Pharmaceuticalco.,Ltd's latest annual total debt in 2023 was 23.66 Million CNY , down -47.63% from previous year.
  • Dali Pharmaceuticalco.,Ltd's latest quarterly total debt in 2024 Q1 was 23.67 Million CNY , up 0.07% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported annual total debt of 45.17 Million CNY in 2022, down -18.62% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported annual total debt of 55.51 Million CNY in 2021, up 177.23% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported quarterly total debt of 20.03 Million CNY for 2024 Q2, down -15.4% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported quarterly total debt of 19.34 Million CNY for 2024 Q3, down -45.06% from previous quarter.

Annual Total Debt Chart of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Historical Annual Total Debt of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Year Total Debt Total Debt Growth
2023 23.66 Million CNY -47.63%
2022 45.17 Million CNY -18.62%
2021 55.51 Million CNY 177.23%
2020 20.02 Million CNY 0.0%
2019 - CNY 0.0%
2018 - CNY -100.0%
2017 50 Million CNY 150.0%
2016 20 Million CNY -60.0%
2015 50 Million CNY 0.0%
2014 50 Million CNY 100.0%
2013 25 Million CNY -16.67%
2012 30 Million CNY 0.0%

Peer Total Debt Comparison of Dali Pharmaceuticalco.,Ltd

Name Total Debt Total Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 1.58 Billion CNY 98.505%
Yabao Pharmaceutical Group Co., Ltd 209 Million CNY 88.678%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 15.79 Billion CNY 99.85%
Harbin Pharmaceutical Group Co., Ltd. 3.55 Billion CNY 99.335%
Tasly Pharmaceutical Group Co., Ltd 2.95 Billion CNY 99.2%
Zhejiang Medicine Co., Ltd. 801.44 Million CNY 97.048%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 839.84 Million CNY 97.183%
Lionco Pharmaceutical Group Co.,Ltd. 565.61 Million CNY 95.816%
Humanwell Healthcare (Group) Co.,Ltd. 9.94 Billion CNY 99.762%
Ginwa Enterprise (Group) Inc. 10.77 Million CNY -119.584%
Joincare Pharmaceutical Group Industry Co.,Ltd. 7.4 Billion CNY 99.68%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 175.68 Million CNY 86.531%
China Animal Husbandry Industry Co., Ltd. 1.45 Billion CNY 98.375%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 9.91 Million CNY -138.772%
Zhejiang Huahai Pharmaceutical Co., Ltd. 7.45 Billion CNY 99.682%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.08 Billion CNY 97.814%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.3 Billion CNY 98.183%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 727.9 Million CNY 96.749%
Chongqing Taiji Industry(Group) Co.,Ltd 4.86 Billion CNY 99.513%
HPGC Renmintongtai Pharmaceutical Corporation 2.33 Billion CNY 98.986%
Nanjing Well Pharmaceutical Group Co.,Ltd. 486.95 Million CNY 95.141%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 995.24 Million CNY 97.622%
Henan Lingrui Pharmaceutical Co., Ltd. 149.26 Million CNY 84.147%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.2 Billion CNY 98.034%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.07 Billion CNY 97.807%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 48.13 Million CNY 50.841%
Zhongzhu Healthcare Holding Co.,Ltd 23.94 Million CNY 1.167%
Beijing Tongrentang Co., Ltd 3.42 Billion CNY 99.309%
KPC Pharmaceuticals, Inc. 1.17 Billion CNY 97.98%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 17.28 Million CNY -36.922%
North China Pharmaceutical Company Ltd. 11.72 Billion CNY 99.798%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 462.87 Million CNY 94.888%
Tibet Weixinkang Medicine Co., Ltd. 7.68 Million CNY -208.02%
China National Medicines Corporation Ltd. 3.15 Billion CNY 99.251%
Zhejiang Hisun Pharmaceutical Co., Ltd. 5.69 Billion CNY 99.584%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.15 Billion CNY 99.249%
ChengDu ShengNuo Biotec Co.,Ltd. 267.22 Million CNY 91.145%
Changchun BCHT Biotechnology Co. 20.47 Million CNY -15.585%
Zhejiang Shengda Bio-Pharm Co., Ltd. 238.44 Million CNY 90.076%
Shanghai Jiaoda Onlly Co.,Ltd 208.92 Million CNY 88.674%
Jiang Zhong Pharmaceutical Co.,Ltd 56.62 Million CNY 58.211%
Mayinglong Pharmaceutical Group Co., LTD. 380.42 Million CNY 93.78%
Cisen Pharmaceutical Co., Ltd. 170.67 Million CNY 86.136%
Hunan Warrant Pharmaceutical Co.,Ltd 24.18 Million CNY 2.146%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 35.72 Billion CNY 99.934%
Jianmin Pharmaceutical Group Co.,Ltd. 501.17 Million CNY 95.279%
Hunan Fangsheng Pharmaceutical Co., Ltd. 679.7 Million CNY 96.519%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.78 Billion CNY 98.675%
Guobang Pharma Ltd. 963.26 Million CNY 97.544%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 659.05 Million CNY 96.41%
Kangmei Pharmaceutical Co., Ltd. 255.01 Million CNY 90.721%
Shandong Buchang Pharmaceuticals Co., Ltd. 3.4 Billion CNY 99.306%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.19 Billion CNY 99.259%
Henan Taloph Pharmaceutical Stock Co.,Ltd 819.3 Million CNY 97.112%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 116.7 Million CNY 79.725%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.62 Billion CNY 99.099%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 446.65 Million CNY 94.702%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.75 Billion CNY 98.648%
Shanghai Yizhong Pharmaceutical Co., Ltd. 44.02 Million CNY 46.256%
Tibet Rhodiola Pharmaceutical Holding Co. 501.52 Million CNY 95.282%
Sichuan Huiyu Pharmaceutical Co., Ltd. 435.5 Million CNY 94.567%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 443.84 Million CNY 94.669%
CanSino Biologics Inc. 2.71 Billion CNY 99.128%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 705.78 Million CNY 96.647%
Shandong Lukang Pharmaceutical Co.,Ltd. 3.43 Billion CNY 99.311%